Regulation of Twist in the metastasis of non-small cell lung cancer by miR-92b

被引:1
|
作者
Liu, X. [1 ]
Tian, X. -D. [1 ]
Liu, Y. [1 ]
Zhang, T. [1 ]
Chen, L. [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Dept Thorac Surg, Beijing, Peoples R China
基金
北京市自然科学基金;
关键词
Non-small cell lung cancer (NSCLC); Twist; miR-92b; BREAST-CANCER; MESENCHYMAL TRANSITION; NSCLC; EXPRESSION; PROLIFERATION; INHIBITION; RESISTANCE; CARCINOMA; INVASION; GROWTH;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: It is well documented that some microRNAs (miRNAs) regulates tumorigenesis and cancer metastases of non-small cell lung cancer (NSCLC). Nevertheless, a role of miR-92b in control of the metastasis of NSCLC has not been acknowledged. MATERIALS AND METHODS: Here, we reported that miR-92b levels were significantly decreased and Twist levels were significantly increased in NSCLC specimens, compared to paired adjacent non-tumor lung tissue. Moreover, the levels of miR-92b and Twist inversely correlated. RESULTS: Bioinformatics analyses and luciferase-reporter assay showed that miR-92b targeted the 3'-UTR of Twist mRNA to inhibit its translation. Overexpression of miR-92b inhibited Twist-mediated cell invasiveness, while depletion of miR-92b increased Twist-mediated cell invasiveness in either a transwell cell migration assay or a scratch wound healing assay. CONCLUSIONS: Together, our data suggest that re-expression of miR-92b may inhibit Twist-mediated NSCLC metastasis.
引用
收藏
页码:4003 / 4010
页数:8
相关论文
共 50 条
  • [41] Up-regulation of lncRNA HULC predicts a poor prognosis and promotes growth and metastasis in non-small cell lung cancer
    Zhang, Jin
    Lu, Shan
    Zhu, Jie-Fang
    Yang, Kun-Peng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (12): : 12415 - 12422
  • [42] Loss of Circulating Exosomal miR-92b is a Novel Biomarker of Colorectal Cancer at Early Stage
    Min, Li
    Chen, Lei
    Liu, Si
    Yu, Yang
    Guo, Qingdong
    Li, Peng
    Zhu, Shengtao
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2019, 16 (09): : 1231 - 1237
  • [43] MiR-130a inhibits cell proliferation and migration via targeting TGFA in non-small cell lung cancer cells
    Zhang, Wenqiang
    Ding, Qian
    Zhang, Na
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (01): : 117 - 127
  • [44] Quantitative Proteomic Analysis of the Metastasis-Inhibitory Mechanism of miR-193a-3p in Non-Small Cell Lung Cancer
    Deng, Wei
    Yan, Mingxia
    Yu, Tao
    Ge, Haiyan
    Lin, Hechun
    Li, Jing
    Liu, Ying
    Geng, Qin
    Zhu, Miaoxin
    Liu, Lei
    He, Xianghuo
    Yao, Ming
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2015, 35 (05) : 1677 - 1688
  • [45] Osteopontin knockdown suppresses non-small cell lung cancer cell invasion and metastasis
    Sun Bing-sheng
    You Jian
    Li Yue
    Zhang Zhen-fa
    Wang Chang-li
    CHINESE MEDICAL JOURNAL, 2013, 126 (09) : 1683 - 1688
  • [46] MiR-613 induces cell cycle arrest by targeting CDK4 in non-small cell lung cancer
    Li, Duo
    Li, Dong-Qiong
    Liu, Dan
    Tang, Xiao-Jun
    CELLULAR ONCOLOGY, 2016, 39 (02) : 139 - 147
  • [47] Hsa-miR-134 suppresses non-small cell lung cancer (NSCLC) development through down-regulation of CCND1
    Sun, Cheng-Cao
    Li, Shu-Jun
    Li, De-Jia
    ONCOTARGET, 2016, 7 (24) : 35960 - 35978
  • [48] MiR-543 promotes tumorigenesis and angiogenesis in non-small cell lung cancer via modulating metastasis associated protein 1
    Wang, Dawei
    Cai, Li
    Tian, Xudong
    Li, Wenjun
    MOLECULAR MEDICINE, 2020, 26 (01)
  • [49] Downregulated miR-18a and miR-92a synergistically suppress non-small cell lung cancer via targeting Sprouty 4
    Zhang, Xinju
    Wang, Xianyi
    Chai, Binshu
    Wu, Zong
    Liu, Xiaomin
    Zou, Heng
    Hua, Ziyi
    Ma, Zhongliang
    Wang, Weiwei
    BIOENGINEERED, 2022, 13 (04) : 11281 - 11295
  • [50] miR-205 as a biological marker in non-small cell lung cancer
    Duan, Baoqi
    Guo, Tao
    Sun, Haoliang
    Cai, Rui
    Rui, Qinglin
    Xi, Zhaoqing
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 91 : 823 - 830